COSM Cosmos Health Inc.
Wholesale-Drugs, Proprietaries & Druggists' Sundries · Nasdaq · SEC CIK 1474167 · 财年截止 12 月 31 日
财务因子 截至 2026-06-30(2026Q2),TTM = 最近四个季度合计
成长
TTM 营收同比33.8%
TTM 净利同比-13.1%
TTM EPS 同比35.6%
营收 3 年复合增长14.8%
净利 3 年复合增长—
利润率
毛利率10.3%
营业利润率-24.9%
净利率-33.1%
自由现金流利润率-13.5%
EBITDA 利润率-23.0%
回报
ROE-104.0%
ROA-39.6%
ROIC(近似)-54.8%
资产周转率1.20x
杠杆与偿债
资产负债率66.4%
债务权益比0.15x
流动比率1.05x
利息覆盖倍数-7.80x
现金质量与分红
经营现金流 / 净利0.40x
应计比率-23.6%
派息率—
资本开支 / 营收0.1%
| 科目 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 | 2024Q32024-09-30 |
|---|---|---|---|---|---|---|---|---|
| 利润表 | ||||||||
| 营业收入 | $1,898.64万 | $1,792.79万 | $1,970.32万 | $1,711.04万 | $1,474.57万 | $1,371.25万 | $1,422.42万 | $1,241.10万 |
| 营业成本 | $1,747.47万 | $1,654.67万 | $1,762.38万 | $1,450.78万 | $1,358.19万 | $1,166.27万 | $1,322.06万 | $1,120.42万 |
| 毛利 | $151.17万 | $138.12万 | $207.93万 | $260.26万 | $116.38万 | $204.98万 | $100.36万 | $120.69万 |
| 研发费用 | $6.86万 | $0 | $41.08万 | $1.83万 | $7.46万 | $1.56万 | $53.33万 | $0 |
| 销售及管理费用 | $206.61万 | $180.02万 | $1,060.96万 | $204.03万 | $149.05万 | $147.87万 | $714.16万 | $178.30万 |
| 营业利润 | -$292.56万 | -$218.42万 | -$1,140.64万 | -$181.87万 | -$264.53万 | -$83.31万 | -$896.68万 | -$223.99万 |
| 利息费用 | $60.24万 | $42.32万 | $65.48万 | $66.92万 | $38.88万 | $18.71万 | $31.98万 | $18.14万 |
| 税前利润 | -$608.65万 | -$280.54万 | -$1,014.59万 | -$535.29万 | -$282.81万 | -$81.81万 | -$954.31万 | -$218.25万 |
| 所得税 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| 归母净利润 | -$608.65万 | -$280.54万 | -$1,014.59万 | -$535.29万 | -$282.81万 | -$81.81万 | -$954.31万 | -$837.76万 |
| EBITDA | -$257.64万 | -$183.77万 | -$1,109.13万 | -$144.08万 | -$229.15万 | -$51.73万 | -$866.20万 | -$193.57万 |
| 基本每股收益 | -0.10 | -0.06 | — | -0.17 | -0.10 | -0.03 | — | -0.45 |
| 稀释每股收益 | -0.10 | -0.06 | — | -0.17 | -0.10 | -0.03 | — | -0.45 |
| 加权平均股数(稀释) | 5,992.32万 | 4,708.76万 | — | 3,062.53万 | 2,875.35万 | 2,603.76万 | — | 1,841.83万 |
| 资产负债表 | ||||||||
| 现金及等价物 | $180.09万 | $51.47万 | $71.57万 | $88.94万 | $65.55万 | $74.29万 | $31.51万 | $331.48万 |
| 短期投资 | $3.75万 | $3.42万 | $4.62万 | $3.32万 | $3.03万 | $2.53万 | $2.11万 | $2.28万 |
| 应收账款 | $1,886.08万 | $1,818.66万 | $1,962.88万 | $1,802.95万 | $1,545.58万 | $1,425.19万 | $1,347.83万 | $1,748.42万 |
| 存货 | $451.86万 | $565.05万 | $577.81万 | $568.37万 | $511.09万 | $473.62万 | $435.54万 | $488.50万 |
| 流动资产 | $3,666.87万 | $3,688.93万 | $3,838.83万 | $3,810.43万 | $3,056.23万 | $2,784.50万 | $2,546.13万 | $3,623.89万 |
| 固定资产净额 | $1,014.01万 | $1,028.02万 | $1,057.89万 | $1,066.48万 | $1,082.04万 | $1,001.61万 | $968.95万 | $1,057.59万 |
| 商誉 | $4.97万 | $4.97万 | $4.97万 | $4.97万 | $4.97万 | $4.97万 | $4.97万 | $4.97万 |
| 无形资产 | $691.62万 | $717.53万 | $752.00万 | $791.09万 | $817.57万 | $775.28万 | $770.68万 | $769.71万 |
| 总资产 | $6,146.20万 | $6,236.90万 | $6,547.75万 | $6,949.28万 | $6,183.56万 | $5,719.19万 | $5,431.19万 | $6,452.00万 |
| 流动负债 | $3,484.27万 | $3,407.68万 | $3,827.18万 | $3,853.43万 | $3,116.66万 | $2,658.60万 | $2,575.75万 | $2,521.12万 |
| 长期债务 | $319.49万 | $345.06万 | $377.53万 | $536.59万 | $519.05万 | $485.23万 | $410.89万 | $426.80万 |
| 总债务 | $319.49万 | $345.06万 | $377.53万 | $536.59万 | $519.05万 | $485.23万 | $410.89万 | $426.80万 |
| 总负债 | $4,078.75万 | $4,254.27万 | $4,705.29万 | $4,635.79万 | $3,560.39万 | $3,124.02万 | $2,977.90万 | $2,954.34万 |
| 归母股东权益 | $2,067.45万 | $1,982.64万 | $1,842.46万 | $2,313.49万 | $2,623.16万 | $2,595.17万 | $2,453.29万 | $3,497.66万 |
| 净债务 | $139.39万 | $293.59万 | $305.97万 | $447.64万 | $453.50万 | $410.94万 | $379.38万 | $95.31万 |
| 期末流通股数 | 8,067.12万 | 4,106.73万 | 4,106.73万 | 3,186.90万 | 2,971.78万 | 2,719.81万 | 2,360.26万 | 2,325.95万 |
| 现金流量表 | ||||||||
| 经营活动现金流 | -$171.83万 | -$106.71万 | -$459.63万 | -$245.50万 | -$120.99万 | -$18.63万 | -$383.38万 | $73.98万 |
| 资本开支 | $6.36万 | $1.14万 | $7,895 | $1.27万 | $2.25万 | $1.25万 | $7.25万 | $22.88万 |
| 自由现金流 | -$178.19万 | -$107.85万 | -$460.42万 | -$246.78万 | -$123.25万 | -$19.88万 | -$390.63万 | $51.10万 |
| 投资活动现金流 | $11.46万 | -$70.90万 | -$106.96万 | -$101.00万 | $7.18万 | -$7,069 | -$100.52万 | -$3.54万 |
| 筹资活动现金流 | $178.87万 | $34.76万 | $469.87万 | $719.22万 | $160.44万 | $56.09万 | $162.01万 | $268.00万 |
| 折旧摊销 | $34.92万 | $34.65万 | $31.51万 | $37.79万 | $35.39万 | $31.58万 | $30.49万 | $30.41万 |
| 股权激励费用 | $55.89万 | $53.58万 | $58.20万 | $0 | $0 | $55.66万 | $58.65万 | $0 |
| 股票回购 | — | — | — | — | — | — | $0 | — |
· 大多数公司不单独披露第四季度:Q4 = 全年 − 前三季累计(标 *),每股收益和股数不能相减,所以 Q4 的 EPS 常为空;现金流量表在季报里只报年初至今累计,单季多为推算。
· 不提供市盈率、市净率等依赖股价的指标(本站不使用授权行情)。空白显示为 —。
数据来源:SEC EDGAR XBRL(公司向 SEC 提交的财报),更新于 2026-11-18 06:30。